Attenhofer Jost Christine H, Schaff Hartzell V, Connolly Heidi M, Danielson Gordon K, Dearani Joseph A, Puga Francisco J, Warnes Carole A
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clin Proc. 2002 Jul;77(7):646-53. doi: 10.4065/77.7.646.
To determine the indications for and spectrum of late reoperations in adults who had previously undergone coarctation repair.
We reviewed clinical, cardiac catheterization, and echocardiographic data and criteria for reoperation, surgical procedures, and outcome in 43 patients who underwent 54 reoperations between 1972 and 1996.
Of the reoperations for recoarctation or associated cardiovascular disease (or both), 20% were performed in asymptomatic patients and 80% in symptomatic patients. Associated cardiovascular disease included bicuspid aortic valve in 36 patients (84%), aortic arch hypoplasia in 12 (28%), true or false aortic aneurysm in 6 (14%), mitral valve disease in 6 (14%), and subvalvular aortic stenosis in 5 (12%). Surgical procedures included 22 recoarctation repairs and 32 other cardiovascular interventions. Simultaneous repair of recoarctation and associated cardiovascular disease was performed as a single-stage repair in 5 reoperations through a median sternotomy using an extra-anatomic, ascending-to-descending aortic bypass, with no complications. One patient died (surgical mortality, 1.9%) of preexisting severe pulmonary vascular obstructive disease.
After coarctation repair, associated cardiovascular diseases are the most common cause for reoperation. An individualized surgical approach is important and may range from valve replacement or recoarctation surgery to extra-anatomic bypass combined with other cardiovascular procedures, enabling simultaneous repair of recoarctation and associated lesions. Despite complex surgical techniques and multiple reoperations, morbidity and mortality were low in our series.
确定既往接受过缩窄修复术的成人患者晚期再次手术的适应证及范围。
我们回顾了1972年至1996年间接受54次再次手术的43例患者的临床、心导管检查、超声心动图数据以及再次手术的标准、手术操作和结果。
在因再缩窄或相关心血管疾病(或两者兼有)而进行的再次手术中,20%在无症状患者中进行,80%在有症状患者中进行。相关心血管疾病包括36例(84%)二叶式主动脉瓣、12例(28%)主动脉弓发育不全、6例(14%)真性或假性主动脉瘤、6例(14%)二尖瓣疾病和5例(12%)主动脉瓣下狭窄。手术操作包括22次再缩窄修复和32次其他心血管介入治疗。5例再次手术通过正中胸骨切开术采用解剖外升主动脉至降主动脉旁路进行了再缩窄与相关心血管疾病的一期联合修复,无并发症发生。1例患者因术前存在严重的肺血管阻塞性疾病死亡(手术死亡率为1.9%)。
缩窄修复术后,相关心血管疾病是再次手术最常见的原因。个体化的手术方法很重要,范围可能从瓣膜置换或再缩窄手术到解剖外旁路联合其他心血管手术,从而能够同时修复再缩窄和相关病变。尽管手术技术复杂且多次进行再次手术,但我们系列中的发病率和死亡率较低。